Test Bulletins

ACL Laboratories continuously strives to provide the best laboratory services possible. Our Test Bulletins and Important Announcements include information regarding new test offerings, changes in test procedures, reference range changes, or modifications in specimen collection protocol and/or new specimen collection devices.

nov. 11, 2020

Important Announcement APTT Reference Range Changes

Effective midnight Tuesday, November 17, 2020, ACL Laboratories will standardize to a new lot of coagulation reagents and will begin using a new reference range, therapeutic range, and critical value for Activated Partial Thromboplastin Time (Test Order Code APTT). Read more

aug. 17, 2020

National Shortage of Aptima Unisex Collection Kits

Due to the wide spread use of these collection devices, there is a national shortage of Aptima® Unisex collection devices used primarily for Chlamydia, Gonorrhea and/or Trichomonas laboratory testing. Please read the attached document for additional information and alternative collection devices acceptable for Chlamydia and/or Gonorrhea testing. Read more

aug. 14, 2020

Acceptable Specimen Collection Devices for SwabOne Testing

Effective August 24, 2020, ACL Laboratories will not be able to perform testing using ESwab™ as a collection device. ACL Laboratories changed the methodology for Women’s Health SwabOne™ testing for vaginal pathogens effective Thursday, July 16, 2020. This new method is FDA approved and requires specimen (vaginal swab) collected using … Read more

aug. 05, 2020

ACL Laboratories Discontinues In-House Testing for Viral Loads

Effective immediately, ACL Laboratories has discontinued in-house testing for the following tests: • BKV Quantitative by PCR (BKVQN) • BKV Quantitative by PCR, Urine (UKVQN) • CMV Quantitative by PCR (CMVQN) • EBV Quantitative by PCR (EBVQN) • Blood Viral Panel Quantitative by PCR (BVPQN) The reagent needed for these … Read more

jul. 23, 2020

2020 Annual Physicians Report

ACL Laboratories maintains an active compliance program that reflects our commitment to conduct business in compliance with all federal, state and local laws. As a participant in federally funded health care programs, ACL Laboratories is required by the Office of Inspector General (OIG) and the US Department of Justice (DOJ) … Read more

jul. 08, 2020

ACL Laboratories Revises SwabOne Testing Menu

Effective Thursday, July 16, 2020, ACL Laboratories will update the Women’s Health SwabOne™ testing menu for vaginal pathogens. Read more

may. 14, 2020

ACL Offers Blood/Serology Testing for COVID-19

ACL Laboratories Offers Blood/Serology Testing for COVID-19 Read more

jan. 28, 2020

Important Announcement Novel Coronavirus Jan 2020

Background A cluster of pneumonia cases was first identified in Wuhan, China in December 2019. The causative agent of cases was later identified as a novel coronavirus that is currently being referred to as 2019-nCoV. It has also been referred to as Wuhan Virus. Within a matter of weeks, the … Read more

nov. 08, 2019

November 2019 Test Bulletin

ACL Laboratories Changes Methodology for Trace Metal Testing -- 2020 CPT Code Changes -- ACL Laboratories Announces Changes in Instrument Platform for Free Kappa and Free Lambda Light Chains -- New Educational Resource for the Workup of Suspected Myeloproliferative Neoplasm (MPN) Read more

aug. 19, 2019

September 2019 Test Bulletin

Total and Free PSA - Stability and Transport Requirement Changes Read more

aug. 13, 2019

ACL Laboratories Makes Significant Changes to Susceptibility Testing

Effective immediately, ACL Laboratories, in conjunction with the Advocate Aurora Health Antimicrobial Stewardship Committee, made a series of significant changes to its microbiology susceptibility testing approaches. Read more

jun. 28, 2019

July 2019 Test Bulletin

New Medicare Cards: Medicare Beneficiary ID (MBI) System Restrictions -- ACL Laboratories Announces New Test Swabone™ Mycoplasma Genitalium by TMA -- (Test Order Code SWOMG) -- ACL Laboratories Discontinues In-House Testing for Test Order Codes: HIVGEN, HIVING, TOXPCR and PRVB19 -- ACL Testing Methodology Changes from Rapid Antigen/Culture Techniques to … Read more

may. 29, 2019

June 2019 Test Bulletin

Heparin Dependent Antibody (PF4IGG, PF4IGR & HDA) Sample Requirements Change -- New Syphilis Total Antibody Assay (Test Order Code SYPT) Read more

mar. 25, 2019

April 2019 Test Bulletin

Urine Erythrocyte (ERYT) Reference Range and Reporting Range Changes for Asymptomatic MicroHematuria (AMH) -- ACL Laboratories Discontinues In-house Testing for Test Order Codes: CY2C19, CYP2D6, HBVGT, TISSMSI -- ALT (Test Order Code GPT) Reference Range Update Read more

feb. 28, 2019

March 2019 Test Bulletin

ACL Laboratories Updates Cytogenetics Testing Forms -- ACL Laboratories Offers New Reportable HIV Integrase Drug for Test Order Code HIVING -- Inactivated Code with REF Code Read more

jan. 30, 2019

February 2019 Test Bulletin

ACL Laboratories Offers Comprehensive Drug Screen – Pain Management Profile 1 (Test Order Code QPNMG1) and deactivates Drug Abuse Panel – Drug Management (Test Order Code DMABUS) -- Pain Management Drug Panel (Test Order Code DRGPM2) -- Pain Management Drug Screen with Interpretation (Test Order Code DRUGPM) Read more

jan. 10, 2019

January 2019 Test Bulletin

ACL Laboratories Implements New Genetic Test Panel for Prenatal Carrier Screening -- Reference Laboratory Discontinues Test Order Codes JAK2R and REF801 -- Notification of Change: Cigna Coverage Policy for Molecular Microbe Testing -- ACL Laboratories Discontinues Treponema Pallidum Antibody, IgG by IFA (FTA-ABS), Serum (Test Order Code FTABR) Read more

dec. 03, 2018

December 2018 Test Bulletin

ACL Implements New Methodology for HSV 1 and 2 Qualitative Testing -- Blue Cross Blue Shield Medicaid Currently Following CMS NCD Guidelines for Medicaid Plan -- Swabone™ MYC/Ureaplasma Panel by PCR (Test Order Code SWOMU) replaces Ureaplasma & Mycoplasma Culture (Test Order Code MYURER) -- 2019 CPT Code Changes -- … Read more

nov. 06, 2018

November 2018 Test Bulletin

ACL Laboratories Revises General Requisition -- CHANGE: Urine Chemistry Storage, Stability, and Transport -- ACL Laboratories Adds Toxin EIA Testing to C. difficile Testing Algorithm -- NT proBNP, Frequently Asked Questions -- Digoxin Specimen Collection/Draw Time -- ACL Laboratories Offers New Quantitative Pain Management Drug Testing Panel Read more

oct. 03, 2018

October 2018 Test Bulletin

Save time, money, resources, and precious blood…by NOT collecting extra specimens “just in case” -- Addendum to Previously Published September 2018 Test Bulletin Article: Activated Partial Thromboplastin Time (Test Order Code APTT) Reference Range Changes -- ACL Implements New Methodology for HIV-1 Viral Load Testing -- ACL Implements New Methodology … Read more